This renewal is in accordance with the automatic renewal clause agreed upon by the parties in the long-term agreement signed three years ago, following the completion of the original contract duration of three years.
Aurobindo Pharma on the weekly chart has decisively broken out above the medium term 'falling channel' at Rs 485 with strong bullish candle indicating a positive bias.